BCMA chimeric antigen receptors and uses thereof Grant US-11952428-B2 United States of America 09 Apr 2024
BCMA chimeric antigen receptors and uses thereof Grant US-11939389-B2 United States of America 26 Mar 2024
Methods for improving the efficacy and expansion of chimeric antigen receptor-expressing… Grant US-11896614-B2 United States of America 13 Feb 2024
BATF3 OVEREXPRESSION IN LYMPHOCYTES Application WO-2023230440-A1 World Intellectual Property Organisation (WIPO) 30 Nov 2023
Chimeric cytokine receptors bearing a PD-1 ectodomain Grant US-11786553-B2 United States of America 17 Oct 2023
Human application of engineered chimeric antigen receptor (CAR) T-cells Grant US-11786582-B2 United States of America 17 Oct 2023
Car T-cells recognizing cancer-specific IL 13Ra2 Grant US-11673935-B2 United States of America 13 Jun 2023
METHOD FOR ENHANCING CELLULAR IMMUNOTHERAPY Application EP-3946426-A4 European Patent Office 04 Jan 2023
MODIFIED CELL EXPRESSING THERAPEUTIC AGENT AND USES THEREOF Application EP-3883585-A4 European Patent Office 14 Dec 2022
METHODS OF MAKING CHIMERIC ANTIGEN RECEPTOR-EXPRESSING CELLS Application EP-4036109-A3 European Patent Office 12 Oct 2022
Methods and compositions for genetically modifying lymphocytes to express polypeptides… Grant US-11325948-B2 United States of America 10 May 2022
COMPOSITIONS AND USES OF SARS-COV-2 TARGETED CHIMERIC ANTIGEN RECEPTOR MODIFIED NK CELLS Application WO-2022035998-A1 World Intellectual Property Organisation (WIPO) 17 Feb 2022
METHODS AND COMPOSITIONS FOR THE REDUCTION OF CHIMERIC ANTIGEN RECEPTOR TONIC SIGNALING Application WO-2022006147-A1 World Intellectual Property Organisation (WIPO) 06 Jan 2022
Methods of treatment with natural killer cells matched for killer immunoglobulin receptor… Grant US-11154572-B2 United States of America 26 Oct 2021
Methods and compositions for transducing lymphocytes and regulating the activity thereof Grant US-11111505-B2 United States of America 07 Sep 2021
A METHOD OF ENGINEERING NATURAL KILLER CELLS TO TARGET CD70-POSITIVE TUMORS Application WO-2021142127-A1 World Intellectual Property Organisation (WIPO) 15 Jul 2021
Enhanced antigen presenting ability of RNA CAR T cells by co-introduction of… Grant US-11028143-B2 United States of America 08 Jun 2021
TUMOR THERAPY COMPOSITIONS AND METHODS Application WO-2021016073-A1 World Intellectual Property Organisation (WIPO) 28 Jan 2021
Method of engineering drug-specific hypersensitive t-cells for immunotherapy by gene… Grant US-10894093-B2 United States of America 19 Jan 2021
Method and compositions for cellular immunotherapy Grant US-10869889-B2 United States of America 22 Dec 2020
Method and compositions for cellular immunotherapy Grant US-10780118-B2 United States of America 22 Sep 2020
TARGETING THE TUMOR MICROENVIRONMENT USING MANIPULATED NKT CELLS Application EP-3692794-A1 European Patent Office 12 Aug 2020
Method and compositions for cellular immunotherapy Grant US-10736918-B2 United States of America 11 Aug 2020
CHIMERIC ANTIGEN RECEPTORS (CARs), COMPOSITIONS AND METHODS THEREOF Application US-20200223918-A1 United States of America 16 Jul 2020
TREATMENT OF CANCER USING CHIMERIC ANTIGEN RECEPTOR Application EP-3593812-A3 European Patent Office 27 May 2020
CHIMERIC ANTIGEN RECEPTORS (CARS), COMPOSITIONS AND METHODS THEREOF Application EP-3474867-A4 European Patent Office 20 May 2020
Treatment of cancer using a CLL-1 chimeric antigen receptor Grant US-10568947-B2 United States of America 25 Feb 2020
Nucleic acid encoding a humanized anti-BCMA chimeric antigen receptor Grant US-10174095-B2 United States of America 08 Jan 2019
TARGETING THE TUMOR MICROENVIRONMENT USING MANIPULATED NKT CELLS Application EP-3326467-A1 European Patent Office 30 May 2018
ENGINEERED LYMPHOCYTES Application WO-2018057915-A1 World Intellectual Property Organisation (WIPO) 29 Mar 2018
METHODS AND COMPOSITIONS FOR TRANSDUCING LYMPHOCYTES AND REGULATING THE ACTIVITY THEREOF Application WO-2018009923-A1 World Intellectual Property Organisation (WIPO) 11 Jan 2018
A METHOD OF ENGINEERING PRODRUG-SPECIFIC HYPERSENSITIVE T-CELLS FOR IMMUNOTHERAPY BY GENE… Application WO-2017178586-A1 World Intellectual Property Organisation (WIPO) 19 Oct 2017
Human application of engineered chimeric antigen receptor (CAR) T-cells Grant US-9629877-B2 United States of America 25 Apr 2017
CAR T-CELLS RECOGNIZING CANCER-SPECIFIC IL 13Rα2 Application WO-2016123143-A1 World Intellectual Property Organisation (WIPO) 04 Aug 2016
ENHANCED ANTIGEN PRESENTING ABILITY OF CAR T CELLS BY CO-INTRODUCTION OF COSTIMULATORY… Application WO-2015112626-A1 World Intellectual Property Organisation (WIPO) 30 Jul 2015
TARGETING THE TUMOR MICROENVIRONMENT USING MANIPULATED NKT CELLS Application WO-2013040371-A2 World Intellectual Property Organisation (WIPO) 21 Mar 2013
ENGINEERED CD19-SPECIFIC T LYMPHOCYTES THAT COEXPRESS IL-15 AND AN INDUCIBLE CASPASE-9… Application US-20130071414-A1 United States of America 21 Mar 2013